Product Description
Experience an astounding breakthrough with Translarna Tablet-engineered for patients with nonsense mutation Duchenne Muscular Dystrophy (nmDMD). Capitalise on this laureate pharmaceutical innovation, designed as a general medicine with Ataluren, offering noteworthy benefits. Each imported, white to off-white 125 mg oral tablet is packaged in a blister pack (30 tablets per box) and ensures the best price for premium quality. Suitable for children over 2 years and adults, Translarna promotes production of functional dystrophin protein. Bargain now on this physician-prescribed solution, approved in select countries and marketed by PTC Therapeutics. Store securely below 30C, away from light and moisture.
Targeted Therapy for nmDMD
Translarna Tablet is specifically recommended for patients diagnosed with Duchenne Muscular Dystrophy caused by nonsense mutations. Administered orally, it is suitable for both adults and children above 2 years, as directed by a physician. A noteworthy advantage is its ability to promote functional dystrophin production, providing a competitive edge over conventional therapies. With a minimum order quantity of just one box, clients can capitalise on this effective and patient-friendly treatment for managing nmDMD symptoms.
Premium Shipping, Certification & Sampling
Translarna Tablets are handed over at acclaimed international FOB Ports across India and shipped with care to preserve their quality. A premium sample policy and supportive certifications are provided to ensure full regulatory compliance and meet market expectations. Customers receive only approved, internationally recognised products, elevating their trust in every transaction. Each shipment is managed with meticulous oversight, guaranteeing the best possible condition and timely delivery for all premium pharmaceutical consignments.
FAQ's of Translarna Tablet:
Q: How should Translarna Tablets be administered?
A: Translarna Tablets should be taken orally, swallowed whole with water without crushing or chewing, strictly following the dosage guidelines provided by your physician.
Q: What is the primary benefit of using Translarna for Duchenne Muscular Dystrophy?
A: Translarna is designed to promote the production of functional dystrophin protein in patients with nmDMD, which can help slow disease progression and improve muscle function.
Q: When can patients expect to start using Translarna?
A: Translarna should be started as advised by a healthcare professional after confirming the appropriate diagnosis of nonsense mutation Duchenne Muscular Dystrophy and securing a valid prescription.
Q: Where is Translarna available, and is it approved globally?
A: Translarna is approved in select countries. Availability may depend on local regulatory guidelines, so it is important to consult with your healthcare provider or supplier regarding access in your area.
Q: What common side effects should one be aware of while using Translarna?
A: The most common side effects reported include vomiting, diarrhea, headache, and abdominal pain. Consult your physician for detailed guidance on managing or reporting side effects.
Q: What is the process for purchasing Translarna from India?
A: To purchase Translarna in India, you need a valid prescription. The exporter, supplier, or trader will arrange for premium shipping, and orders are handed over at designated FOB ports with all necessary certifications ensured.